Gain Therapeutics (GANX) Earnings Date & Reports

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GANX is expected to report earnings to rise 17.63% to -18 cents per share on August 07

Gain Therapeutics GANX Stock Earnings Reports

Q2'25

Est.

$-0.19

Q1'25

Beat

by $0.03

Q4'24

Beat

by $0.10

Q3'24

Beat

by $0.04

Q2'24

Missed

by $0.23

The last earnings report on May 14 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 124.07K shares outstanding, the current market capitalization sits at 53.06M.

View a ticker or compare two or three

Compare

GANX